Colchicine and COVID-19

dc.creatorCorral, Pablo
dc.creatorCorral, Gonzalo
dc.creatorDiaz, Rafael
dc.date2020
dc.date.accessioned2026-03-13T21:41:47Z
dc.date.available2026-03-13T21:41:47Z
dc.descriptionIn Argentina, we started COLCOVID Trial to test the effects of colchicine on moderate-/high-risk hospitalized COVID-19 patients with the aim of reducing mortality. This study is a phase 3 multicenter, controlled trial; our protocol was published in ClinicalTrial.gov on March 31, 2020.
dc.descriptionFil: Corral, Pablo. Universidad FASTA. Facultad de Ciencias Médicas; Argentina.
dc.descriptionFil: Corral, Gonzalo. Clínica 25 de Mayo. Hospital Interzonal General de Agudos "Dr. Oscar E. Alende". Servicio de Infectología; Argentina
dc.descriptionFil: Diaz, Rafael. Estudios Cardiológicos Latinoamérica. Instituto Cardiovascular de Rosario; Argentina
dc.formatapplication/pdf
dc.identifier.citationCorral, P., Corral, G. and Diaz, R. (2020), Colchicine and COVID-19. The Journal of Clinical Pharmacology, 60: 978-978. https://doi.org/10.1002/jcph.1684
dc.identifier.issn1552-4604
dc.identifier.urihttps://dspace.ufasta.edu.ar/handle/123456789/87939
dc.languageeng
dc.publisherThe Journal of Clinical Pharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licences/by-nc-nd/3.0/deed.es_AR
dc.sourceThe Journal of Clinical Pharmacology, 60, 978-978.
dc.subjectCoranivirus
dc.subjectCOVID-19
dc.subjectColchicina
dc.titleColchicine and COVID-19
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/acceptedVersion

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Corral_2020_1552-4604.pdf
Size:
56.81 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: